| 000 | 01751 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514005959.0 | ||
| 264 | 0 | _c20011004 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/s0014-2999(01)01222-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aConigrave, A D | |
| 245 | 0 | 0 |
_aP2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cAug 2001 |
||
| 300 |
_a157-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAdenosine _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine Monophosphate _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAdenosine-5'-(N-ethylcarboxamide) _xpharmacology |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xgenetics |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 |
_aRNA, Messenger _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2 _xgenetics |
| 650 | 0 | 4 | _aReceptors, Purinergic P2X7 |
| 700 | 1 | _aFernando, K C | |
| 700 | 1 | _aGu, B | |
| 700 | 1 | _aTasevski, V | |
| 700 | 1 | _aZhang, W | |
| 700 | 1 | _aLuttrell, B M | |
| 700 | 1 | _aWiley, J S | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 426 _gno. 3 _gp. 157-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-2999(01)01222-5 _zAvailable from publisher's website |
| 999 |
_c11451661 _d11451661 |
||